After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Kymera Therapeutics Inc is $3.84B. A total of 1.11 million shares were traded on the day, compared to an average of 768.32K shares.
In the most recent transaction, Jacobs Bruce N. sold 79,220 shares of KYMR for 50.00 per share on Sep 17 ’25. After the transaction, the Chief Financial Officer now owns 227,409 company shares. In a previous transaction on Sep 17 ’25, BRUCE N. JACOBS bought 79,220 shares at 48.78 per share.
Among the insiders who sold shares, Mainolfi Nello disposed of 30,000 shares on Sep 16 ’25 at a per-share price of $49.00. This resulted in the Chief Executive Officer holding 660,482 shares of KYMR after the transaction. In another insider transaction, Mainolfi Nello bought 30,000 shares at $49.00 per share on Sep 16 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, KYMR has a high of $53.27 and a low of $19.44.
As of this writing, KYMR has an earnings estimate of -$0.84 per share for the current quarter. EPS was calculated based on a consensus of 18.0 estimates, with a high estimate of $0.09 per share and a lower estimate of -$1.15. The company reported an EPS of -$0.82 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. KYMR’s latest balance sheet shows that the firm has $442.42M in Cash & Short Term Investments as of fiscal 2021. There were $17.96M in debt and $92.54M in liabilities at the time. Its Book Value Per Share was $13.77, while its Total Shareholder’s Equity was $459.64M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KYMR is Buy with a score of 4.87.
